Confo Therapeutics

Drug discovery technology based on G-protein-coupled receptors (GPCRs)

placeBrussels, Brussels, Belgium calendar_todayFounded 2015 groups114 employees language confotherapeutics.com

Registered entities

Social engagement

Social engagement: 10.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include BioGeneration Ventures, Wellington Partners Venture Capital, Ackermans & van Haaren.

Investor typeCountShare
Venture capital850%
Bank & private debt16%
Other / undisclosed744%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

23 Sep 2025 · Development Translational Pharmacology Lead · Ghent, Belgium

Based on job postings tracked across public sources.

Recent activity

28 May 2026
Event
Jefferies Global Healthcare Conference
30 Apr 2026
Milestone
regulatory
Coming soon